nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphemanil Methylsulfate—Diphenylpyraline—HRH1—atherosclerosis	0.0774	0.443	CrCbGaD
Diphemanil Methylsulfate—Ketoprofen—CXCL8—atherosclerosis	0.0368	0.21	CrCbGaD
Diphemanil Methylsulfate—Tamoxifen—ESR2—atherosclerosis	0.025	0.143	CrCbGaD
Diphemanil Methylsulfate—Tamoxifen—ESR1—atherosclerosis	0.0154	0.0881	CrCbGaD
Diphemanil Methylsulfate—Ketoprofen—PTGS2—atherosclerosis	0.0107	0.0613	CrCbGaD
Diphemanil Methylsulfate—Ketoprofen—ALB—atherosclerosis	0.00956	0.0547	CrCbGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.00147	0.00178	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—EDN1—atherosclerosis	0.00146	0.00177	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—EDN1—atherosclerosis	0.00146	0.00177	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—CCL5—atherosclerosis	0.00145	0.00176	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—CCL5—atherosclerosis	0.00145	0.00175	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Regulation of Actin Cytoskeleton—MAPK3—atherosclerosis	0.00144	0.00175	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—CX3CR1—atherosclerosis	0.00144	0.00175	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—CASR—atherosclerosis	0.00144	0.00175	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Regulation of Actin Cytoskeleton—MAPK3—atherosclerosis	0.00144	0.00175	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CX3CR1—atherosclerosis	0.00144	0.00174	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CASR—atherosclerosis	0.00144	0.00174	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—CX3CL1—atherosclerosis	0.00141	0.00171	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CX3CL1—atherosclerosis	0.00141	0.00171	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—ABCG1—atherosclerosis	0.0014	0.00169	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—HRH1—atherosclerosis	0.00138	0.00167	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—HRH1—atherosclerosis	0.00137	0.00166	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—CNR2—atherosclerosis	0.00134	0.00162	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CNR2—atherosclerosis	0.00134	0.00162	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.00131	0.00159	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—FABP4—atherosclerosis	0.00131	0.00159	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—LCAT—atherosclerosis	0.00131	0.00159	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.00131	0.00159	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—MAPK8—atherosclerosis	0.0013	0.00158	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—APOA4—atherosclerosis	0.00129	0.00156	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CYP7A1—atherosclerosis	0.00127	0.00153	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—AGT—atherosclerosis	0.00121	0.00147	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—AGT—atherosclerosis	0.00121	0.00147	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CYP27A1—atherosclerosis	0.00117	0.00142	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—CCL3—atherosclerosis	0.00115	0.0014	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CCL3—atherosclerosis	0.00115	0.00139	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—CCR2—atherosclerosis	0.00115	0.00139	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—EDNRA—atherosclerosis	0.00115	0.00139	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—CCR2—atherosclerosis	0.00114	0.00139	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—EDNRA—atherosclerosis	0.00114	0.00139	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—F2—atherosclerosis	0.00112	0.00136	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—F2—atherosclerosis	0.00112	0.00136	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—GHRL—atherosclerosis	0.00112	0.00135	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—GHRL—atherosclerosis	0.00111	0.00135	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—ALOX5AP—atherosclerosis	0.00111	0.00134	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—ALOX15—atherosclerosis	0.00111	0.00134	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PLA2G2A—atherosclerosis	0.00111	0.00134	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—APOA2—atherosclerosis	0.00111	0.00134	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—ABCG5—atherosclerosis	0.0011	0.00133	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—APOA4—atherosclerosis	0.00108	0.00131	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—APOA4—atherosclerosis	0.00108	0.00131	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.00108	0.00131	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.00107	0.0013	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—LPA—atherosclerosis	0.00106	0.00128	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—CCR2—atherosclerosis	0.00104	0.00126	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—EDNRA—atherosclerosis	0.00104	0.00126	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.00104	0.00126	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CCR2—atherosclerosis	0.00104	0.00126	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—EDNRA—atherosclerosis	0.00104	0.00126	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.00104	0.00125	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—BGN—atherosclerosis	0.00103	0.00124	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—GHRL—atherosclerosis	0.00102	0.00123	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—APOA5—atherosclerosis	0.00101	0.00123	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—GHRL—atherosclerosis	0.00101	0.00123	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—CCL2—atherosclerosis	0.001	0.00121	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—CCL2—atherosclerosis	0.000997	0.00121	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CCL4—atherosclerosis	0.000996	0.00121	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CCL4—atherosclerosis	0.000993	0.0012	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—KNG1—atherosclerosis	0.000981	0.00119	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—KNG1—atherosclerosis	0.000978	0.00119	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PLA2G1B—atherosclerosis	0.000977	0.00118	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000975	0.00118	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—AGTR1—atherosclerosis	0.000972	0.00118	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—ALOX5—atherosclerosis	0.000943	0.00114	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—APOA2—atherosclerosis	0.000931	0.00113	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—APOA2—atherosclerosis	0.000928	0.00112	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—KNG1—atherosclerosis	0.000891	0.00108	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—KNG1—atherosclerosis	0.000888	0.00108	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—UTS2—atherosclerosis	0.000888	0.00108	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—AGTR1—atherosclerosis	0.000886	0.00107	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—UTS2—atherosclerosis	0.000885	0.00107	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—AGTR1—atherosclerosis	0.000883	0.00107	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CX3CR1—atherosclerosis	0.000851	0.00103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CASR—atherosclerosis	0.000851	0.00103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CX3CR1—atherosclerosis	0.000848	0.00103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CASR—atherosclerosis	0.000848	0.00103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—NAMPT—atherosclerosis	0.000846	0.00103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—LIPC—atherosclerosis	0.000841	0.00102	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—APOC3—atherosclerosis	0.000836	0.00101	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CX3CL1—atherosclerosis	0.000835	0.00101	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CX3CL1—atherosclerosis	0.000832	0.00101	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—IL6—atherosclerosis	0.000831	0.00101	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—LDLR—atherosclerosis	0.00083	0.00101	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—EDN1—atherosclerosis	0.000827	0.001	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—EDN1—atherosclerosis	0.000824	0.000999	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—CCL5—atherosclerosis	0.000821	0.000994	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—CCL5—atherosclerosis	0.000818	0.000991	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CETP—atherosclerosis	0.000811	0.000983	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CNR2—atherosclerosis	0.000791	0.000959	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—CXCL8—atherosclerosis	0.000791	0.000958	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—MMP3—atherosclerosis	0.000789	0.000957	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CNR2—atherosclerosis	0.000789	0.000956	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—CXCL8—atherosclerosis	0.000788	0.000955	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000788	0.000955	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—MMP3—atherosclerosis	0.000787	0.000954	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000785	0.000952	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—PRKCG—atherosclerosis	0.00078	0.000945	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—PRKCG—atherosclerosis	0.000778	0.000942	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—SCARB1—atherosclerosis	0.000777	0.000941	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—EDN1—atherosclerosis	0.000751	0.00091	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—EDN1—atherosclerosis	0.000749	0.000907	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—CCL5—atherosclerosis	0.000745	0.000903	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CCL5—atherosclerosis	0.000743	0.0009	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—HMGCR—atherosclerosis	0.000734	0.000889	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—PRKCG—atherosclerosis	0.000708	0.000859	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—PRKCG—atherosclerosis	0.000706	0.000856	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—VWF—atherosclerosis	0.000705	0.000855	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—VWF—atherosclerosis	0.000703	0.000852	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—APOC3—atherosclerosis	0.000701	0.000849	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—APOC3—atherosclerosis	0.000699	0.000847	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—LDLR—atherosclerosis	0.000697	0.000844	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—LDLR—atherosclerosis	0.000694	0.000842	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—AGT—atherosclerosis	0.000686	0.000832	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—AGT—atherosclerosis	0.000684	0.000829	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CCL3—atherosclerosis	0.00068	0.000825	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CCL3—atherosclerosis	0.000678	0.000822	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—ABCA1—atherosclerosis	0.000654	0.000792	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—NCF1—atherosclerosis	0.000652	0.00079	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—NCF1—atherosclerosis	0.00065	0.000787	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—F2—atherosclerosis	0.000634	0.000769	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—F2—atherosclerosis	0.000632	0.000766	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—AGT—atherosclerosis	0.000623	0.000755	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—AGT—atherosclerosis	0.000621	0.000753	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CCR2—atherosclerosis	0.000615	0.000746	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—EDNRA—atherosclerosis	0.000615	0.000746	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—EDNRA—atherosclerosis	0.000613	0.000743	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CCR2—atherosclerosis	0.000613	0.000743	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CYBA—atherosclerosis	0.000613	0.000742	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CYBA—atherosclerosis	0.000611	0.00074	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000607	0.000736	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000605	0.000733	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PLAT—atherosclerosis	0.0006	0.000727	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GHRL—atherosclerosis	0.0006	0.000727	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PARP1—atherosclerosis	0.0006	0.000727	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PLAT—atherosclerosis	0.000598	0.000724	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PARP1—atherosclerosis	0.000598	0.000724	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GHRL—atherosclerosis	0.000598	0.000724	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—F2—atherosclerosis	0.000576	0.000698	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—F2—atherosclerosis	0.000574	0.000696	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—HMOX1—atherosclerosis	0.000561	0.00068	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000551	0.000668	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	0.000549	0.000666	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—APOB—atherosclerosis	0.000537	0.000651	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—KNG1—atherosclerosis	0.000526	0.000638	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—KNG1—atherosclerosis	0.000525	0.000636	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	0.000523	0.000634	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—GSTM1—atherosclerosis	0.000523	0.000633	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	0.000522	0.000632	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	0.000513	0.000622	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—LPL—atherosclerosis	0.000513	0.000622	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	0.000512	0.00062	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PLG—atherosclerosis	0.00051	0.000618	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PLG—atherosclerosis	0.000508	0.000616	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—GPX1—atherosclerosis	0.000501	0.000607	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CD36—atherosclerosis	0.000488	0.000591	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	0.000483	0.000585	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	0.000481	0.000583	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—MMP3—atherosclerosis	0.000466	0.000565	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—MMP3—atherosclerosis	0.000465	0.000563	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—IGF2—atherosclerosis	0.000464	0.000563	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—IGF2—atherosclerosis	0.000463	0.000561	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—MTHFR—atherosclerosis	0.000462	0.00056	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PPARA—atherosclerosis	0.000453	0.000549	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—APOB—atherosclerosis	0.000451	0.000546	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—APOB—atherosclerosis	0.000449	0.000545	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000447	0.000542	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	0.000445	0.00054	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—EDN1—atherosclerosis	0.000444	0.000538	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—EDN1—atherosclerosis	0.000442	0.000536	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CCL5—atherosclerosis	0.00044	0.000533	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—AGT—atherosclerosis	0.000439	0.000532	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CCL5—atherosclerosis	0.000439	0.000532	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—LPL—atherosclerosis	0.00043	0.000522	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—APOE—atherosclerosis	0.00043	0.000521	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—LPL—atherosclerosis	0.000429	0.00052	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CAV1—atherosclerosis	0.000426	0.000516	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—APOA1—atherosclerosis	0.000425	0.000515	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	0.000418	0.000507	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	0.000417	0.000506	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—SPP1—atherosclerosis	0.000408	0.000494	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—SPP1—atherosclerosis	0.000406	0.000492	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	0.000406	0.000492	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	0.000405	0.00049	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PIK3CG—atherosclerosis	0.000388	0.00047	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	0.000377	0.000457	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	0.000376	0.000456	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PPARG—atherosclerosis	0.000375	0.000454	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—AGT—atherosclerosis	0.000368	0.000446	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—INS—atherosclerosis	0.000367	0.000445	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—AGT—atherosclerosis	0.000367	0.000445	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—APOE—atherosclerosis	0.000361	0.000437	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—LEP—atherosclerosis	0.000361	0.000437	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—APOE—atherosclerosis	0.00036	0.000436	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—LEP—atherosclerosis	0.00036	0.000436	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CAV1—atherosclerosis	0.000357	0.000433	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—APOA1—atherosclerosis	0.000357	0.000432	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CAV1—atherosclerosis	0.000356	0.000432	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—APOA1—atherosclerosis	0.000355	0.000431	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ESR1—atherosclerosis	0.000344	0.000417	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ESR1—atherosclerosis	0.000343	0.000416	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—F2—atherosclerosis	0.00034	0.000412	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—F2—atherosclerosis	0.000339	0.000411	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—ALB—atherosclerosis	0.000337	0.000408	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	0.000326	0.000395	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	0.000325	0.000393	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—NOS3—atherosclerosis	0.000322	0.00039	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	0.000312	0.000378	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	0.000311	0.000377	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—INS—atherosclerosis	0.000308	0.000374	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—INS—atherosclerosis	0.000307	0.000372	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CCL2—atherosclerosis	0.000303	0.000368	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CCL2—atherosclerosis	0.000302	0.000366	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—IGF1—atherosclerosis	0.000298	0.000361	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—IGF1—atherosclerosis	0.000297	0.00036	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PTGS2—atherosclerosis	0.000295	0.000357	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	0.000283	0.000343	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	0.000282	0.000342	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—NOS3—atherosclerosis	0.00027	0.000328	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—NOS3—atherosclerosis	0.000269	0.000327	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	0.00024	0.000291	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	0.000239	0.00029	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	0.000232	0.000281	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	0.000231	0.00028	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—IL6—atherosclerosis	0.000228	0.000276	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—IL6—atherosclerosis	0.000227	0.000275	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—MMP9—atherosclerosis	0.000217	0.000263	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—MMP9—atherosclerosis	0.000216	0.000262	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	0.000215	0.00026	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	0.000214	0.000259	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	0.000211	0.000256	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	0.00021	0.000255	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	0.00021	0.000255	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	0.00021	0.000254	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	0.000195	0.000236	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	0.000194	0.000235	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—STAT3—atherosclerosis	0.000193	0.000234	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—STAT3—atherosclerosis	0.000192	0.000233	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	0.000184	0.000223	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	0.000184	0.000223	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	0.000179	0.000217	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	0.000178	0.000216	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—AKT1—atherosclerosis	0.000148	0.000179	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—IL6—atherosclerosis	0.000135	0.000163	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—IL6—atherosclerosis	0.000134	0.000163	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—AKT1—atherosclerosis	0.000124	0.000151	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—AKT1—atherosclerosis	0.000124	0.00015	CbGpPWpGaD
